AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Arch Biopartners Inc.

CAD 0.86 -$0.39 (-31.20%)
TSXV · 14 Sep 2026 14:24 UTC
Previous Close
CAD 0.92
Day Range
CAD 0.86CAD 0.92
Year Range
CAD 0.39CAD 1.66
Market Cap
58.42M
AVG Volume
62.59K
Trailing/Forward PE
-20.24/-
PEG ratio
0.27
Dividend Yield
-
Next Earnings Date
2027-02-02
Primary Exchange
Toronto Stock Exchange VenturesCA
Revenue (CAD)
-1M01M2M3M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
ARCH.V Revenue (CAD) by quarter
PeriodRevenue (CAD)
26 Q30
26 Q20
26 Q10
25 Q40
25 Q30
25 Q20
25 Q10
24 Q4-361K
24 Q30
24 Q22.18M
Net Income (CAD)
-2M-1.5M-1M-500K024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
ARCH.V Net Income (CAD) by quarter
PeriodNet Income (CAD)
26 Q3-475.11K
26 Q2-521.01K
26 Q1-1.56M
25 Q4-269.76K
25 Q3-242.33K
25 Q2-624.35K
25 Q1-416K
24 Q4-1.1M
24 Q3-885K
24 Q2-1.15M
Operating Income (CAD)
-1.5M-1M-500K024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
ARCH.V Operating Income (CAD) by quarter
PeriodOperating Income (CAD)
26 Q3-437.21K
26 Q2-459.43K
26 Q1-1.48M
25 Q4-216.91K
25 Q3-275.33K
25 Q2-521.15K
25 Q1-357K
24 Q4-671K
24 Q3-863K
24 Q2-1.14M
EBITDA (CAD)
-1.5M-1M-500K024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
ARCH.V EBITDA (CAD) by quarter
PeriodEBITDA (CAD)
26 Q3-437.21K
26 Q2-459.43K
26 Q1-1.48M
25 Q4-207.47K
25 Q3-183.46K
25 Q2-558K
25 Q1-346K
24 Q4-987K
24 Q3-35.26K
24 Q2-1.06M
Cash Flows (CAD)
-1M-500K0500K24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
ARCH.V Cash Flows (CAD) by quarter
PeriodCash Flows (CAD)
26 Q3-520.99K
26 Q2-89.11K
26 Q1-849.94K
25 Q4-257.9K
25 Q3105.51K
25 Q2-528.64K
25 Q1-903.05K
24 Q4-469.84K
24 Q3-864.11K
24 Q2-465.38K
EPS (CAD)
-0.03-0.02-0.01024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
ARCH.V EPS (CAD) by quarter
PeriodEPS (CAD)
26 Q3-0.01
26 Q2-0.01
26 Q1-0.02
25 Q4-0
25 Q3-0
25 Q2-0.01
25 Q1-0.01
24 Q4-0.02
24 Q3-0.01
24 Q2-0.02
Expenses (CAD)
-1M01M2M3M4MR&DSG&ACapex24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
ARCH.V Expenses (CAD) by quarter
PeriodExpenses (CAD)
26 Q3380.18K
26 Q2355.14K
26 Q11.4M
25 Q416.33K
25 Q3317.18K
25 Q2470.19K
25 Q1333.78K
24 Q4722.3K
24 Q3721.19K
24 Q23.13M
Cash & Debt (CAD)
02M4M6MCashLong Term DebtShort Term Debt24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
ARCH.V Cash & Debt (CAD) by quarter
PeriodCash & Debt (CAD)
26 Q32.91K
26 Q2436.76K
26 Q14.16K
25 Q42.1K
25 Q3167.46K
25 Q210.03K
25 Q154.85K
24 Q42.97K
24 Q343.95K
24 Q26.56K
Debt ratios
-4-3-2-1024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
ARCH.V Debt ratios by quarter
PeriodDebt ratios
26 Q3-1.05
26 Q2-0.98
26 Q1-1.08
25 Q4-2.19
25 Q3-1.09
25 Q2-1.23
25 Q1-1.14
24 Q4-1
24 Q3-3.69
24 Q2-2.94
Margins
-200%0%200%400%22 Q122 Q222 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q4
ARCH.V Margins by quarter
PeriodMargins
24 Q4207.91%
24 Q2-25.7%
24 Q143.07%
23 Q4266.61%
23 Q3-169.29%
23 Q2-24.97%
23 Q1-7.54%
22 Q4162.29%
22 Q2-21.99%
22 Q16.7%
Return on Capital
0%20%40%60%24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
ARCH.V Return on Capital by quarter
PeriodReturn on Capital
26 Q311.92%
26 Q214.3%
26 Q143.33%
25 Q46.95%
25 Q36.63%
25 Q216.57%
25 Q19.76%
24 Q425.39%
24 Q313.5%
24 Q217.86%
Shares Outstanding
020M40M60M80M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
ARCH.V Shares Outstanding by quarter
PeriodShares Outstanding
26 Q367.93M
26 Q266.94M
26 Q166.11M
25 Q466.11M
25 Q366.11M
25 Q265.47M
25 Q164.94M
24 Q464.65M
24 Q362.76M
24 Q262.76M
Book Value Per Share (CAD)
-0.15-0.1-0.05-024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
ARCH.V Book Value Per Share (CAD) by quarter
PeriodBook Value Per Share (CAD)
26 Q3-0.06
26 Q2-0.05
26 Q1-0.05
25 Q4-0.06
25 Q3-0.06
25 Q2-0.06
25 Q1-0.07
24 Q4-0.07
24 Q3-0.1
24 Q2-0.1
Total Assets (CAD)
0500K1M1.5M2M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
ARCH.V Total Assets (CAD) by quarter
PeriodTotal Assets (CAD)
26 Q357.22K
26 Q2463.16K
26 Q125.03K
25 Q4104.53K
25 Q3266.46K
25 Q2549.64K
25 Q1533.53K
24 Q4935.62K
24 Q31.54M
24 Q21.79M
PE Ratio
2004006008001000med 417.53Apr 22May 22Jun 22Jun 22Jul 22Aug 22Sep 22
ARCH.V PE Ratio by quarter
PeriodPE Ratio
Sep 22212.54
Sep 22227.57
Sep 22229.71
Sep 22232.57
Aug 22241.88
Aug 22240.45
Aug 22246.89
Aug 22248.32
Jul 22251.9
Jul 22246.89
Jul 22248.32
Jul 22261.2
Jun 22214.68
Jun 22573.87
Jun 22598.46
Jun 22610.76
Jun 22604.61
May 22627.15
May 22641.5
May 22739.88
May 22809.56
Apr 22807.51
Apr 22821.86
Apr 22836.21
Apr 22840.3
Apr 22856.7
Free Cash Flow Yield
-6%-5%-4%-3%-2%-1%med -2.38%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ARCH.V Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-1.77%
Sep 26-1.6%
Aug 26-1.5%
Aug 26-1.46%
Aug 26-1.47%
Aug 26-1.54%
Jul 26-2.01%
Jul 26-1.87%
Jul 26-1.94%
Jul 26-1.9%
Jul 26-1.77%
Jun 26-2.44%
Jun 26-3.46%
Jun 26-4.54%
Jun 26-4.73%
May 26-5.2%
May 26-5.2%
May 26-5.39%
May 26-5.32%
May 26-5.32%
Apr 26-4.88%
Apr 26-5.03%
Apr 26-4.14%
Apr 26-3.86%
Mar 26-4.36%
Mar 26-4.2%
Mar 26-3.38%
Mar 26-3%
Feb 26-2.85%
Feb 26-2.6%
Feb 26-2.52%
Feb 26-3.07%
Jan 26-2.42%
Jan 26-1.9%
Jan 26-1.74%
Jan 26-1.82%
Jan 26-1.92%
Dec 25-2.19%
Dec 25-2.19%
Dec 25-2.14%
Dec 25-2.17%
Nov 25-2.64%
Nov 25-2.59%
Nov 25-2.59%
Nov 25-2.56%
Oct 25-2.74%
Oct 25-2.77%
Oct 25-2.77%
Oct 25-2.47%
Oct 25-2.3%
Sep 25-3.02%
Sep 25-2.54%
Sep 25-2.56%
Sep 25-2.56%
Aug 25-2.51%
Aug 25-2.56%
Aug 25-2.51%
Aug 25-2.43%
Aug 25-2.41%
Jul 25-2.58%
Jul 25-2.44%
Jul 25-2.46%
Jul 25-2.41%
Jun 25-2.21%
Jun 25-2.39%
Jun 25-2.24%
Jun 25-2.24%
May 25-2.34%
May 25-2.38%
May 25-2.43%
May 25-2.42%
May 25-2.41%
Apr 25-2.38%
Apr 25-2.31%
Apr 25-2.2%
Apr 25-2.46%
Mar 25-2.07%
Mar 25-1.96%
Mar 25-1.94%
Mar 25-2.04%
Feb 25-1.94%
Feb 25-1.91%
Feb 25-1.93%
Feb 25-1.92%
Jan 25-1.98%
Jan 25-1.89%
Jan 25-1.93%
Jan 25-1.86%
Jan 25-1.81%
Dec 24-2.38%
Dec 24-2.46%
Dec 24-2.33%
Dec 24-2.23%
Nov 24-2.23%
Nov 24-2.23%
Nov 24-2.17%
Nov 24-2.12%
Nov 24-2.23%
Oct 24-2.18%
Oct 24-2.03%
Price to Sales
-400-2000200med 58.86Apr 24Jul 24Nov 24Feb 25May 25Sep 25Dec 25
ARCH.V Price to Sales by quarter
PeriodPrice to Sales
Dec 25-227.07
Dec 25-227.07
Dec 25-232.56
Dec 25-228.9
Nov 25-188.61
Nov 25-192.28
Nov 25-192.28
Nov 25-194.11
Oct 25-181.29
Oct 25-179.46
Oct 25-179.46
Oct 25-201.43
Oct 25-216.08
Sep 25-253.89
Sep 25-301.04
Sep 25-299.23
Sep 25-299.23
Aug 25-304.67
Aug 25-299.23
Aug 25-304.67
Aug 25-315.55
Aug 25-317.37
Jul 25-297.42
Jul 25-313.74
Jul 25-311.93
Jul 25-317.37
Jun 2566.97
Jun 2561.98
Jun 2566.26
Jun 2566.26
May 2563.41
May 2562.34
May 2560.92
May 2561.27
May 2561.63
Apr 2562.34
Apr 2564.12
Apr 2567.33
Apr 2560.2
Mar 2553.34
Mar 2556.39
Mar 2557
Mar 2554.25
Feb 2557
Feb 2557.91
Feb 2557.3
Feb 2557.61
Jan 2555.78
Jan 2558.52
Jan 2557.3
Jan 2559.43
Jan 2560.96
Dec 2483.03
Dec 2480.31
Dec 2484.85
Dec 2488.48
Nov 2488.48
Nov 2488.48
Nov 2491.2
Nov 2493.01
Nov 2488.48
Oct 2490.74
Oct 2497.1
Oct 2484.85
Oct 2484.39
Sep 2475.75
Sep 2468.64
Sep 2465.71
Sep 2462.78
Aug 2460.68
Aug 2459.43
Aug 2462.36
Aug 2462.78
Aug 2464.87
Jul 2466.54
Jul 2465.71
Jul 2467.8
Jul 2470.31
Jun 2456.83
Jun 2455.82
Jun 2457.17
Jun 2459.2
May 2456.49
May 2457.17
May 2457.51
May 2457.85
May 2459.88
Apr 2464.28
Apr 2480.51
Apr 2480.17
Apr 2480.17
Mar 2470.71
Mar 2477.34
Mar 2469.45
Mar 2455.24
Mar 2447.98
Feb 2447.98
Feb 2444.82
Feb 2445.14
Feb 2444.19
EV/EBITDA
0200040006000med 371.54Apr 22May 22Jul 22Aug 22Sep 22Nov 22Dec 22
ARCH.V EV/EBITDA by quarter
PeriodEV/EBITDA
Dec 223574.52
Dec 223793.02
Dec 223831.58
Dec 223780.17
Nov 223805.87
Nov 223934.4
Nov 224101.49
Nov 224191.46
Oct 224255.73
Oct 224242.87
Oct 223831.58
Oct 223831.58
Sep 223947.26
Sep 22156.52
Sep 22167.37
Sep 22168.92
Sep 22170.99
Aug 22177.71
Aug 22176.67
Aug 22181.33
Aug 22182.36
Jul 22184.94
Jul 22181.33
Jul 22182.36
Jul 22191.66
Jun 22158.07
Jun 22289.52
Jun 22301.67
Jun 22307.75
Jun 22304.71
May 22315.85
May 22322.94
May 22371.54
May 22405.97
Apr 22404.96
Apr 22412.04
Apr 22419.13
Apr 22421.16
Apr 22429.26
Price/Operating Cashflow
050001000015000med 578.81Apr 22May 22Jul 22Aug 22Jul 24Aug 24Sep 24
ARCH.V Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2410786.09
Sep 249773.04
Sep 249355.89
Sep 248938.75
Aug 248640.79
Aug 248462.02
Aug 248879.16
Aug 248938.75
Aug 249236.71
Jul 249475.08
Jul 249355.89
Jul 249653.85
Jul 2410011.4
Sep 22180.71
Sep 22193.49
Sep 22195.32
Sep 22197.75
Aug 22205.66
Aug 22204.45
Aug 22209.92
Aug 22211.14
Jul 22214.18
Jul 22209.92
Jul 22211.14
Jul 22222.09
Jun 22182.54
Jun 22448.94
Jun 22468.18
Jun 22477.8
Jun 22472.99
May 22490.62
May 22501.85
May 22578.81
May 22633.32
Apr 22631.72
Apr 22642.94
Apr 22654.16
Apr 22657.37
Apr 22670.2
Price to Book
55006000650070007500med 6616.64Apr 16Apr 16Apr 16May 16May 16Jun 16Jun 16
ARCH.V Price to Book by quarter
PeriodPrice to Book
Jun 165671.41
Jun 166549.12
Jun 166886.71
Jun 166751.67
May 167021.74
May 166751.67
May 166616.64
May 166616.64
Apr 166211.54
Apr 166279.06
Apr 166616.64
Apr 166481.61
Apr 166751.67
Arch Biopartners Inc.
ARCH.V
Stockpicker

Video analysis: ARCH.V

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.